# Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)

> **NCT00771342** · PHASE2 · COMPLETED · sponsor: **Nitric BioTherapeutics, Inc** · enrollment: 50 (estimated)

## Conditions studied

- Tinea

## Interventions

- **DRUG:** Nitric Oxide
- **DRUG:** Nitrogen

## Key facts

- **NCT ID:** NCT00771342
- **Lead sponsor:** Nitric BioTherapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00771342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00771342, "Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00771342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*